Observational studyPloS one2017

Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers.

Delphine Hequet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.